Get started
Author

Shinichi Kanazu

Observed names: S. Kanazu, Shin-Ichi Kanazu
Institution: AstraZeneca (Japan)
OpenAlex ID: A5079227401
Risk of pneumococcal diseases in adults with underlying medical conditions: a retrospective, cohort study using two Japanese healthcare databases
2018 · Kentaro Imai, Tanaz Petigara, et al. · BMJ Open · 43
PDF
Phase I and pharmacokinetic study of vorinostat (suberoylanilide hydroxamic acid) in Japanese patients with solid tumors
2009 · Yutaka Fujiwara, Noboru Yamamoto, et al. · Cancer Science · 41
PDF
Revaccination with 23-valent pneumococcal polysaccharide vaccine in the Japanese elderly is well tolerated and elicits immune responses
2016 · Kenji Kawakami, Hiroyuki Kishino, et al. · Vaccine · 17
PDF
[A nationwide survey of PPSV23 vaccine coverage rates and their related factors among the elderly in Japan, 2016].
2018 · Yoshitaka Murakami, Yuuji Nishiwaki, et al. · PubMed · 13
Factors associated with PPSV23 coverage among older adults in Japan: a nationwide community-based survey
2019 · Yoshitaka Murakami, Shinichi Kanazu, et al. · BMJ Open · 12
PDF
Time interval of revaccination with 23-valent pneumococcal polysaccharide vaccine more than 5 years does not affect the immunogenicity and safety in the Japanese elderly
2018 · Kenji Kawakami, Hiroyuki Kishino, et al. · Human Vaccines & Immunotherapeutics · 11
Predicting steady‐state HbA 1c responses to sitagliptin in patients with type 2 diabetes mellitus*
2009 · S. Kanazu, Y. Horie, et al. · Diabetes Obesity and Metabolism · 3
The continued impact of COVID-19 during the Omicron era on immunocompromised individuals in Japan
2025 · Toshibumi Taniguchi, Mitsuru Hoshino, et al. · Journal of Infection and Chemotherapy · 2
Clinical characteristics and COVID-19-related outcomes of immunocompromised patients receiving tixagevimab/cilgavimab pre-exposure prophylaxis in Japan
2024 · Toshibumi Taniguchi, Tomoyuki Homma, et al. · Journal of Infection and Chemotherapy · 2
PDF
Responses to 23-valent Pneumococcal Polysaccharide Vaccine in Adults 70–79 With Chronic Diseases
2017 · K. Kawakami, H. Kishino, et al. · Innovation in Aging
PDF
Antibody Responses to 23-valent Pneumococcal Polysaccharide Vaccine After Primary and Revaccination
2017 · K. Kawakami, H. Kishino, et al. · Innovation in Aging
Works count: 11
Citation count: 144
H-index: 6
I10-index: 6
Year
Topic
Type